Frontiers in Hypertrophic Cardiomyopathy Forum
|
08:00-10:00 大宴会厅C（3楼） |
|---|
| 主席 Chairmen | 王建安 Jianan WANG, 陈韵岱 Yundai CHEN | ||
| 主持 Moderators | 张健 Jian ZHANG, 金玮 Wei JIN | ||
|
08:00-08:05 |
开场视频 Opening Video |
||
|
08:05-08:15 |
领势向心：主席致辞 Leading Forward, Uniting Together- Chairman's Opening |
||
|
08:15-08:35 |
负重前行：中国肥厚型心肌病诊疗的多维挑战 The Burdened Journey: Multifaceted Challenges in Diagnosis and Treatment HCM in China |
杜昕 Xin DU | |
|
08:35-08:55 |
创新驱动：从药理机制到临床验证： 新型CMI药物的创新探索 Innovation Driven: From Pharmacological Mechanisms to Clinical Validation — Exploring Next in Class CMI Therapeutics |
蒋学俊 Xuejun JIANG | |
|
08:55-09:15 |
未来破局：新型CMI药物的最新研究数据 Future Directions: Latest Research Data on Next in Class CMI Drugs |
张书宁 Shuning ZHANG | |
|
09:15-09:35 |
启心时代：大咖讨论1：如何提升中国肥厚型心肌病诊断率？ New Era of Cardiac Care - Expert Panel 1: Advancing the Diagnostic Rate for Hypertrophic Cardiomyopathy in China |
王江 Jiang WANG | |
|
09:15-09:35 |
启心时代：大咖讨论1：如何提升中国肥厚型心肌病诊断率？ New Era of Cardiac Care - Expert Panel 1: Advancing the Diagnostic Rate for Hypertrophic Cardiomyopathy in China |
孙志军 Zhijun SUN | |
|
09:15-09:35 |
启心时代：大咖讨论1：如何提升中国肥厚型心肌病诊断率？ New Era of Cardiac Care - Expert Panel 1: Advancing the Diagnostic Rate for Hypertrophic Cardiomyopathy in China |
修建成 Jiancheng XIU | |
|
09:15-09:35 |
启心时代：大咖讨论1：如何提升中国肥厚型心肌病诊断率？ New Era of Cardiac Care - Expert Panel 1: Advancing the Diagnostic Rate for Hypertrophic Cardiomyopathy in China |
陈玉成 Yucheng CHEN | |
|
09:15-09:35 |
启心时代：大咖讨论1：如何提升中国肥厚型心肌病诊断率？ New Era of Cardiac Care - Expert Panel 1: Advancing the Diagnostic Rate for Hypertrophic Cardiomyopathy in China |
李浪 Lang LI | |
|
09:35-09:55 |
启心时代：大咖讨论2：如何构建中国肥厚型心肌病综合管理体系？ New Era of Cardiac Care - Expert Panel 2: Building a Comprehensive Management System for Hypertrophic Cardiomyopathy in China |
高传玉 Chuanyu GAO | |
|
09:35-09:55 |
启心时代：大咖讨论2：如何构建中国肥厚型心肌病综合管理体系？ New Era of Cardiac Care - Expert Panel 2: Building a Comprehensive Management System for Hypertrophic Cardiomyopathy in China |
陈新敬 Xinjing CHEN | |
|
09:35-09:55 |
启心时代：大咖讨论2：如何构建中国肥厚型心肌病综合管理体系？ New Era of Cardiac Care - Expert Panel 2: Building a Comprehensive Management System for Hypertrophic Cardiomyopathy in China |
彭道泉 Daoquan PENG | |
|
09:35-09:55 |
启心时代：大咖讨论2：如何构建中国肥厚型心肌病综合管理体系？ New Era of Cardiac Care - Expert Panel 2: Building a Comprehensive Management System for Hypertrophic Cardiomyopathy in China |
陶凌 Ling TAO | |
|
09:35-09:55 |
启心时代：大咖讨论2：如何构建中国肥厚型心肌病综合管理体系？ New Era of Cardiac Care - Expert Panel 2: Building a Comprehensive Management System for Hypertrophic Cardiomyopathy in China |
苑海涛 Haitao YUAN | |
|
09:55-10:00 |
会议总结 Meeting Summary |
||
Lipid Forum-3
|
10:00-12:00 大宴会厅C（3楼） |
|---|
| 主席 Chairmen | 王建安 Jianan WANG, 刘斌 Bin LIU | ||
| 主持 Moderators | 王焱 Yan WANG, 高传玉 Chuanyu GAO, 鄢华 Hua YAN | ||
|
10:00-10:05 |
大会主席致辞 Opening Remarks |
王建安 Jianan WANG | |
|
10:05-10:25 |
ESC 2025热点聚焦：中国原研PCSK9i 助力血脂管理新方案 ESC 2025 Highlights: China's Indigenous PCSK9 Inhibitor Contributes to Novel Lipid-Management Strategies |
施仲伟 Zhongwei SHI | |
|
10:25-10:45 |
从单抗发展史看中国企业的创新与突破 Innovation and Breakthroughs of Chinese Enterprises: Perspectives from the Evolution of Monoclonal Antibodies |
史旭波 Xubo SHI | |
|
10:45-11:05 |
PCI术后高效血脂管理策略 Strategies for Efficient Lipid Management Post-Percutaneous Coronary Intervention |
陆峰 Feng LU | |
|
11:05-11:25 |
FLAVOUR IV：使用PCSK9抑制剂进一步降脂对冠状动脉CT血管造影提示的高危斑块的心血管结局影响 Further Lipid-Lowering with PCSK9 Inhibitors for Cardiovascular Outcomes in High-Risk Coronary Plaques Assessed by CT Angiography |
胡新央 Xinyang HU | |
|
11:25-11:55 |
专家访谈：血脂治疗展望 Discussions and Prospects in Lipid Management |
周建华 Jianhua ZHOU | |
|
11:25-11:55 |
专家访谈：血脂治疗展望 Discussions and Prospects in Lipid Management |
于雪 Xue YU | |
|
11:25-11:55 |
专家访谈：血脂治疗展望 Discussions and Prospects in Lipid Management |
陈样新 Yangxin CHEN | |
|
11:25-11:55 |
专家访谈：血脂治疗展望 Discussions and Prospects in Lipid Management |
曲新凯 Xinkai QU | |
|
11:25-11:55 |
专家访谈：血脂治疗展望 Discussions and Prospects in Lipid Management |
薛玉增 Yuzeng XUE | |
|
11:25-11:55 |
专家访谈：血脂治疗展望 Discussions and Prospects in Lipid Management |
袁杰 Jie YUAN | |
|
11:55-12:00 |
总结 Summary |
定 待 | |
Valvular Heart Disease Forum–7
|
13:30-15:30 大宴会厅C（3楼） |
|---|
|
产品上市会 |
||||
|---|---|---|---|---|
| 主席 Chairman | 王建安 Jianan WANG | |||
| 主持 Moderator | 王力涵 Lihan WANG | |||
|
13:30-13:33 |
开场视频 Opening Ceremony Video |
|||
|
13:38-13:43 |
开场致辞 Opening Ceremony Address |
|||
|
13:38-13:43 |
致欢迎语 Welcoming Remarks |
|||
|
13:48-13:53 |
全国专家寄语视频 National Experts' Video Messages |
|||
|
13:48-13:53 |
启动仪式 Launch Ceremony |
|||
|
13:53-13:55 |
合影 Group Photo |
|||
|
学术研讨会 |
||||
|---|---|---|---|---|
| 主席 Chairmen | 王焱 Yan WANG, 袁义强 Yiqiang YUAN, 张俊杰 Junjie ZHANG | |||
| 主持 Moderators | 方臻飞 Zhenfei FANG, 傅国胜 Guosheng FU, 罗建方 Jianfang LUO, 陶凌 Ling TAO, 杨毅宁 Yining YANG, 李永在 Yongzai LI | |||
| 讨论嘉宾 Discussants | 丛广志 Guangzhi CONG, 何晋 Jin HE, 李林锋 Linfeng LI, 周浩 Hao ZHOU | |||
|
13:55-14:10 |
J-VALVE TF 两年随访数据解读 Interpretation of Two-Year Follow-Up Data of J-VALVE TF |
刘先宝 Xianbao LIU | ||
|
14:10-14:25 |
首款经血管入路反流瓣产品特点介绍&讨论 The Pioneer Transvascular Anti-Regurgitation Valve: Product Profile and Technical Discussion |
吴永健 Yongjian WU | ||
|
14:25-14:40 |
AR介入治疗研究进展及AR专用器械的临床优势 Research Progress in AR-Assisted Interventional Therapy and Clinical Advantages of AR-Specific Devices |
陈韵岱 Yundai CHEN | ||
|
14:40-14:55 |
经血管入路TAVR治疗AR标准手术流程详解&讨论 Transvascular TAVR for Aortic Regurgitation: A Comprehensive Review of the Technique |
Dongming HOU | ||
|
14:55-15:10 |
首款经血管入路反流瓣的前世今生与创新之路 The First Transvascular Valve for Aortic Regurgitation: From Concept to Clinical Reality |
蓝天翔 Tianxiang LAN | ||
|
15:10-15:30 |
首款经血管入路反流瓣 在复杂病例中的应用&讨论 | Simon LAM | ||
Frontline Management Forum
|
15:30-18:00 大宴会厅C（3楼） |
|---|
| 主持 Moderators | 周华 Hua ZHOU, 蒋天武 Tianwu JIANG, 杜兆辉 Zhaohui DU, 葛承辉 Chenghui GE, 张磊 Lei ZHANG | ||
| 讨论嘉宾 Discussants | 徐文杰 Wenjie XU, 杨建敏 Jianmin YANG, 陈碧华 Bihua CHEN, 严培玲 Peiling YAN | ||
|
15:30-15:35 |
开场致辞 Opening Remarks |
王建安 Jianan WANG | |
|
15:35-15:55 |
创新防控模式 提升管理效能 ——关于慢性病防控工作的思考与建议 Innovating Prevention and Control Models to Enhance Management Efficiency ——Reflections and Suggestions on Chronic Disease Prevention and Control Work |
赵振平 Zhenping ZHAO | |
|
15:55-16:15 |
浙江省基层慢病防控情况介绍 Introduction to CHC Prevention and Control of Chronic Diseases in Zhejiang Province |
钟节鸣 Jieming ZHONG | |
|
16:15-16:35 |
三甲医院在我国慢病防控工作中的职责与担当 The Role and Responsibility of Tertiary Hospitals in Chronic Disease Prevention and Control in China |
陈雯艾 Wenai CHEN | |
|
16:35-16:55 |
H2H血压达标案例分享 H2H Blood Pressure Target Achievement Case Sharing |
但淑杰 Shujie DAN | |
|
16:55-17:15 |
县域医共体慢性病一体化管理体系构建与探索 Development and Exploration of an Integrated Management System for Chronic Diseases within County Healthcare Consortiums |
吴斌 Bin WU | |
|
17:15-17:35 |
“优效化？个体化？ — 高质量控压的关键策略思辨” | 谢建洪 Jianhong XIE | |
|
17:35-17:55 |
讨论 Discussion |
||
|
17:55-18:00 |
总结 Summary |
||